Compared with the control inhibitor, miR-1827 inhibitor significantly promoted the growth of HCT116 p53+/+ xenograft tumor but showed a limited effect on HCT116 p53−/− xenograft tumors (Figure 6B). Here, TP53 is linked to neoplasm.